MovDisordV3, Main, Exploration, bibRecord, 004C45

SSRI‐induced reversal of levodopa benefit in two patients with dopa‐responsive dystonia

Identifieur interne : 004C45 ( Main/Exploration ); précédent : 004C44; suivant : 004C46

SSRI‐induced reversal of levodopa benefit in two patients with dopa‐responsive dystonia

Auteurs : Dilip Mathen [Royaume-Uni] ; C. David Marsden [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]

Source :

Movement Disorders [ 0885-3185 ] ; 1999-09.

RBID : ISTEX:3699BBDC016BAC8174274F465E15B51BDBDB0CC9

Descripteurs français

Pascal (Inist)
- Antidépresseur, Dopamine, Dystonie, Etude cas, Fluoxétine, Homme, Inhibiteur recapture, Lévodopa, Phényléthylamine dérivé, Sérotonine, Toxicité, Traitement, Venlafaxine.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Adult, Antidepressant agent, Antiparkinson Agents (therapeutic use), Case study, Dopamine, Dystonia, Dystonia (chemically induced), Dystonia (drug therapy), Female, Fluoxetine, Fluoxetine (adverse effects), Human, Humans, Levodopa, Levodopa (therapeutic use), Recurrence, Reuptake inhibitor, Serotonin, Serotonin Uptake Inhibitors (adverse effects), Stress, Psychological (drug therapy), Stress, Psychological (psychology), Toxicity, Treatment, Venlafaxine.
MESH :
- chemical , adverse effects : Fluoxetine, Serotonin Uptake Inhibitors.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- chemically induced : Dystonia.
- drug therapy : Dystonia, Stress, Psychological.
- psychology : Stress, Psychological.
- Adult, Female, Humans, Recurrence.

Url:

https://api.istex.fr/document/3699BBDC016BAC8174274F465E15B51BDBDB0CC9/fulltext/pdf

DOI: 10.1002/1531-8257(199909)14:5<874::AID-MDS1028>3.0.CO;2-Q

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">SSRI‐induced reversal of levodopa benefit in two patients with dopa‐responsive dystonia</title>
<author><name sortKey="Mathen, Dilip" sort="Mathen, Dilip" uniqKey="Mathen D" first="Dilip" last="Mathen">Dilip Mathen</name>
</author>
<author><name sortKey="Marsden, C David" sort="Marsden, C David" uniqKey="Marsden C" first="C. David" last="Marsden">C. David Marsden</name>
</author>
<author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3699BBDC016BAC8174274F465E15B51BDBDB0CC9</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1002/1531-8257(199909)14:5<874::AID-MDS1028>3.0.CO;2-Q</idno>
<idno type="url">https://api.istex.fr/document/3699BBDC016BAC8174274F465E15B51BDBDB0CC9/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002852</idno>
<idno type="wicri:Area/Istex/Curation">002852</idno>
<idno type="wicri:Area/Istex/Checkpoint">003412</idno>
<idno type="wicri:doubleKey">0885-3185:1999:Mathen D:ssri:induced:reversal</idno>
<idno type="wicri:Area/Main/Merge">007944</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:99-0475677</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002D45</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003A79</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002D25</idno>
<idno type="wicri:doubleKey">0885-3185:1999:Mathen D:ssri:induced:reversal</idno>
<idno type="wicri:Area/Main/Merge">007B74</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:10495057</idno>
<idno type="wicri:Area/PubMed/Corpus">004112</idno>
<idno type="wicri:Area/PubMed/Curation">004112</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004110</idno>
<idno type="wicri:Area/Ncbi/Merge">000139</idno>
<idno type="wicri:Area/Ncbi/Curation">000139</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000139</idno>
<idno type="wicri:doubleKey">0885-3185:1999:Mathen D:ssri:induced:reversal</idno>
<idno type="wicri:Area/Main/Merge">007717</idno>
<idno type="wicri:Area/Main/Curation">004C45</idno>
<idno type="wicri:Area/Main/Exploration">004C45</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">SSRI‐induced reversal of levodopa benefit in two patients with dopa‐responsive dystonia</title>
<author><name sortKey="Mathen, Dilip" sort="Mathen, Dilip" uniqKey="Mathen D" first="Dilip" last="Mathen">Dilip Mathen</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neurology, Institute of Neurology, University College London, Queen Square, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marsden, C David" sort="Marsden, C David" uniqKey="Marsden C" first="C. David" last="Marsden">C. David Marsden</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neurology, Institute of Neurology, University College London, Queen Square, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neurology, Institute of Neurology, University College London, Queen Square, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="1999-09">1999-09</date>
<biblScope unit="vol">14</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="874">874</biblScope>
<biblScope unit="page" to="876">876</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">3699BBDC016BAC8174274F465E15B51BDBDB0CC9</idno>
<idno type="DOI">10.1002/1531-8257(199909)14:5<874::AID-MDS1028>3.0.CO;2-Q</idno>
<idno type="ArticleID">MDS1028</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antidepressant agent</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Case study</term>
<term>Dopamine</term>
<term>Dystonia</term>
<term>Dystonia (chemically induced)</term>
<term>Dystonia (drug therapy)</term>
<term>Female</term>
<term>Fluoxetine</term>
<term>Fluoxetine (adverse effects)</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa</term>
<term>Levodopa (therapeutic use)</term>
<term>Recurrence</term>
<term>Reuptake inhibitor</term>
<term>Serotonin</term>
<term>Serotonin Uptake Inhibitors (adverse effects)</term>
<term>Stress, Psychological (drug therapy)</term>
<term>Stress, Psychological (psychology)</term>
<term>Toxicity</term>
<term>Treatment</term>
<term>Venlafaxine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Fluoxetine</term>
<term>Serotonin Uptake Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Dystonia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dystonia</term>
<term>Stress, Psychological</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Stress, Psychological</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Recurrence</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antidépresseur</term>
<term>Dopamine</term>
<term>Dystonie</term>
<term>Etude cas</term>
<term>Fluoxétine</term>
<term>Homme</term>
<term>Inhibiteur recapture</term>
<term>Lévodopa</term>
<term>Phényléthylamine dérivé</term>
<term>Sérotonine</term>
<term>Toxicité</term>
<term>Traitement</term>
<term>Venlafaxine</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Mathen, Dilip" sort="Mathen, Dilip" uniqKey="Mathen D" first="Dilip" last="Mathen">Dilip Mathen</name>
</region>
<name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
<name sortKey="Marsden, C David" sort="Marsden, C David" uniqKey="Marsden C" first="C. David" last="Marsden">C. David Marsden</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004C45 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004C45 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:3699BBDC016BAC8174274F465E15B51BDBDB0CC9
   |texte=   SSRI‐induced reversal of levodopa benefit in two patients with dopa‐responsive dystonia
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

SSRI‐induced reversal of levodopa benefit in two patients with dopa‐responsive dystonia

SSRI‐induced reversal of levodopa benefit in two patients with dopa‐responsive dystonia

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.